Cargando…
Advent of CRISPR Based Immunotherapy in Hematologic Malignancies
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018007/ https://www.ncbi.nlm.nih.gov/pubmed/29953127 |
_version_ | 1783334871847927808 |
---|---|
author | Perez, RK Chen, R Kang, R Perez, AR |
author_facet | Perez, RK Chen, R Kang, R Perez, AR |
author_sort | Perez, RK |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6018007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60180072018-06-25 Advent of CRISPR Based Immunotherapy in Hematologic Malignancies Perez, RK Chen, R Kang, R Perez, AR J Oncopathol Clin Res Article 2018-03-30 2018 /pmc/articles/PMC6018007/ /pubmed/29953127 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Perez, RK Chen, R Kang, R Perez, AR Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title | Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title_full | Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title_fullStr | Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title_full_unstemmed | Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title_short | Advent of CRISPR Based Immunotherapy in Hematologic Malignancies |
title_sort | advent of crispr based immunotherapy in hematologic malignancies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018007/ https://www.ncbi.nlm.nih.gov/pubmed/29953127 |
work_keys_str_mv | AT perezrk adventofcrisprbasedimmunotherapyinhematologicmalignancies AT chenr adventofcrisprbasedimmunotherapyinhematologicmalignancies AT kangr adventofcrisprbasedimmunotherapyinhematologicmalignancies AT perezar adventofcrisprbasedimmunotherapyinhematologicmalignancies |